研究者データベース


フリーワードで探す

全文検索となっています

楠本 茂クスモト シゲル

所属部署医学研究科血液・腫瘍内科学分野
職名准教授
メールアドレスskusumotmed.nagoya-cu.ac.jp
ホームページURLhttp://ncu-ketsuekishuyo.jp/
生年月日
Last Updated :2019/09/20

研究者基本情報

基本情報

    プロフィール:座右の銘は出水兵児修養掟です。学生および若い医師が成長できる医療環境を整え、より良いチーム医療を目指して、日々精進して参りたいと存じます。

学歴

  • 名古屋市立大学

研究活動情報

研究キーワード

    悪性リンパ腫, 多発性骨髄腫, HBV再活性化

論文

  • Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy., Kusumoto S, Arcaini L, Hong X, Jin J, Kim WS, Kwong YL, Peters MG, Tanaka Y, Zelenetz AD, Kuriki H, Fingerle-Rowson G, Nielsen T, Ueda E, Piper-Lepoutre H, Sellam G, Tobinai K, Blood,   2018年10月, 査読有り
  • Human T-cell lymphotropic/leukemia virus type 1 (HTLV-1) Tax-specific T-cell exhaustion in HTLV-1-infected individuals., Masaki A, Ishida T, Suzuki S, Ito A, Narita T, Kinoshita S, Ri M, Kusumoto S, Komatsu H, Inagaki H, Ueda R, Iida S, Cancer science, 109, (8) 2383 - 2390,   2018年08月, 査読有り
  • CCR4 mutations associated with superior outcome of adult T-cell leukemia/lymphoma under mogamulizumab treatment., Sakamoto Y, Ishida T, Masaki A, Murase T, Yonekura K, Tashiro Y, Tokunaga M, Utsunomiya A, Ito A, Kusumoto S, Iida S, Ueda R, Inagaki H, Blood, 132, (7) 758 - 761,   2018年08月, 査読有り
  • Cyclin-dependent kinase 9 as a potential specific molecular target in NK cell leukemia/lymphoma., Kinoshita S, Ishida T, Ito A, Narita T, Masaki A, Suzuki S, Yoshida T, Ri M, Kusumoto S, Komatsu H, Shimizu N, Inagaki H, Kuroda T, Scholz A, Ueda R, Sanda T, Iida S, Haematologica,   2018年08月, 査読有り
  • Clinical evaluation of a novel and highly sensitive immunoassay for anti-hepatitis B core antigen using a fully automated immunochemical analyzer., Izumida K, Kaneko A, Takahashi K, Kusumoto S, Narita T, Takami A, Iida S, Aoyagi K, Tanaka Y, Hepatology research : the official journal of the Japan Society of Hepatology,   2018年07月, 査読有り
  • Potent antitumor effect of combination therapy with sub-optimal doses of Akt inhibitors and pomalidomide plus dexamethasone in multiple myeloma., Kinoshita S, Ri M, Kanamori T, Aoki S, Yoshida T, Narita T, Totani H, Ito A, Kusumoto S, Ishida T, Komatsu H, Iida S, Oncology letters, 15, (6) 9450 - 9456,   2018年06月, 査読有り
  • Bortezomib plus dexamethasone vs thalidomide plus dexamethasone for relapsed or refractory multiple myeloma., Iida S, Wakabayashi M, Tsukasaki K, Miyamoto K, Maruyama D, Yamamoto K, Takatsuka Y, Kusumoto S, Kuroda J, Ando K, Kikukawa Y, Masaki Y, Kobayashi M, Hanamura I, Asai H, Nagai H, Shimada K, Tsukamoto N, Inoue Y, Tobinai K, Cancer science, 109, (5) 1552 - 1561,   2018年05月, 査読有り
  • Potent anti-tumor activity of a syringolin analog in multiple myeloma: a dual inhibitor of proteasome activity targeting β2 and β5 subunits., Yoshida T, Ri M, Kanamori T, Aoki S, Ashour R, Kinoshita S, Narita T, Totani H, Masaki A, Ito A, Kusumoto S, Ishida T, Komatsu H, Kitahata S, Chiba T, Ichikawa S, Iida S, Oncotarget, 9, (11) 9975 - 9991,   2018年02月, 査読有り
  • Clinical significance of tryptophan catabolism in Hodgkin lymphoma., Masaki A, Ishida T, Maeda Y, Ito A, Suzuki S, Narita T, Kinoshita S, Takino H, Yoshida T, Ri M, Kusumoto S, Komatsu H, Inagaki H, Ueda R, Choi I, Suehiro Y, Iida S, Cancer science, 109, (1) 74 - 83,   2018年01月, 査読有り
  • Cognitive dysfunction among newly diagnosed older patients with hematological malignancy: frequency, clinical indicators and predictors., Aiki S, Okuyama T, Sugano K, Kubota Y, Imai F, Nishioka M, Ito Y, Iida S, Komatsu H, Ishida T, Kusumoto S, Akechi T, Japanese journal of clinical oncology, 48, (1) 61 - 67,   2018年01月, 査読有り
  • [Sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance mimicking POEMS syndrome]., Kanamori T, Kusumoto S, Okita K, Hagiwara S, Kato C, Nakashima T, Murakami S, Narita T, Ito A, Ri M, Ishida T, Komatsu H, Matsukawa N, Iida S, [Rinsho ketsueki] The Japanese journal of clinical hematology, 59, (2) 161 - 166,   2018年, 査読有り
  • [Treatment strategy for newly diagnosed Hodgkin lymphoma: current evidence]., Kusumoto S, [Rinsho ketsueki] The Japanese journal of clinical hematology, 59, (10) 2117 - 2126,   2018年
  • Low expression of neural cell adhesion molecule, CD56, is associated with low efficacy of bortezomib plus dexamethasone therapy in multiple myeloma., Yoshida T, Ri M, Kinoshita S, Narita T, Totani H, Ashour R, Ito A, Kusumoto S, Ishida T, Komatsu H, Iida S, PloS one, 13, (5) ,   2018年, 査読有り
  • JSH guideline for tumors of hematopoietic and lymphoid tissues-leukemia: 3. Acute lymphoblastic leukemia/lymphoblastic lymphoma (ALL/LBL)., Takeuchi J, Kusumoto S, Akiyama H, Kanda Y, Izutsu K, International journal of hematology, 106, (6) 732 - 747,   2017年12月
  • Safety and efficacy of daratumumab in Japanese patients with relapsed or refractory multiple myeloma: a multicenter, phase 1, dose-escalation study., Iida S, Suzuki K, Kusumoto S, Ri M, Tsukada N, Abe Y, Aoki M, Inagaki M, International journal of hematology, 106, (4) 541 - 551,   2017年10月, 査読有り
  • Novel monitoring of hepatitis B reactivation based on ultra-high sensitive hepatitis B surface antigen assay., Shinkai N, Kusumoto S, Murakami S, Ogawa S, Ri M, Matsui T, Tamori A, Toyoda H, Ishida T, Iida S, Tanaka Y, Liver international : official journal of the International Association for the Study of the Liver, 37, (8) 1138 - 1147,   2017年08月, 査読有り
  • Cyclin-dependent kinase 9 is a novel specific molecular target in adult T-cell leukemia/lymphoma., Narita T, Ishida T, Ito A, Masaki A, Kinoshita S, Suzuki S, Takino H, Yoshida T, Ri M, Kusumoto S, Komatsu H, Imada K, Tanaka Y, Takaori-Kondo A, Inagaki H, Scholz A, Lienau P, Kuroda T, Ueda R, Iida S, Blood, 130, (9) 1114 - 1124,   2017年08月, 査読有り
  • Does cognitive decline decrease health utility value in older adult patients with cancer?, Akechi T, Aiki S, Sugano K, Uchida M, Yamada A, Komatsu H, Ishida T, Kusumoto S, Iida S, Okuyama T, Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, 17, (3) 149 - 154,   2017年05月, 査読有り
  • Nationwide prospective and retrospective surveys for hepatitis B virus reactivation during immunosuppressive therapies., Mochida S, Nakao M, Nakayama N, Uchida Y, Nagoshi S, Ido A, Mimura T, Harigai M, Kaneko H, Kobayashi H, Tsuchida T, Suzuki H, Ura N, Nakamura Y, Bessho M, Dan K, Kusumoto S, Sasaki Y, Fujii H, Suzuki F, Ikeda K, Yamamoto K, Takikawa H, Tsubouchi H, Mizokami M, Journal of gastroenterology, 51, (10) 999 - 1010,   2016年10月, 査読有り
  • The value of serum Wisteria floribunda agglutinin-positive human Mac-2-binding protein as a predictive marker for hepatitis C virus-related complications after systemic chemotherapy., Totani H, Kusumoto S, Tanaka Y, Suzuki N, Hagiwara S, Kinoshita S, Iio E, Ito A, Ri M, Ishida T, Komatsu H, Iida S, International journal of hematology, 104, (3) 384 - 391,   2016年09月, 査読有り
  • Guillain-Barré syndrome after allogeneic bone marrow transplantation: Case report and literature review., Yoshida T, Ueki Y, Suzuki T, Kawagashira Y, Koike H, Kusumoto S, Ida S, Oguri T, Omura M, Sobue, Matsukawa N, eNeurologicalSci, 4, 52 - 55,   2016年09月, 査読有り
  • Phase I study of once weekly treatment with bortezomib in combination with lenalidomide and dexamethasone for relapsed or refractory multiple myeloma., Totani H, Ri M, Kato C, Nakashima T, Suzuki N, Hagiwara S, Kanamori T, Murakami S, Masuda A, Kinoshita S, Yoshida T, Narita T, Ito A, Kusumoto S, Ishida T, Komatsu H, Iida S, International journal of hematology, 103, (3) 316 - 321,   2016年03月, 査読有り
  • Labial salivary gland biopsy for diagnosing immunoglobulin light chain amyloidosis: a retrospective analysis., Suzuki T, Kusumoto S, Yamashita T, Masuda A, Kinoshita S, Yoshida T, Takami-Mori F, Takino H, Ito A, Ri M, Ishida T, Komatsu H, Ueda M, Ando Y, Inagaki H, Iida S, Annals of hematology, 95, (2) 279 - 285,   2016年01月, 査読有り
  • Multicenter cooperative case survey of hepatitis B virus reactivation by chemotherapeutic agents., Takahashi H, Ikeda M, Kumada T, Osaki Y, Kondo S, Kusumoto S, Ohkawa K, Nadano S, Furuse J, Kudo M, Ito K, Yokoyama M, Okusaka T, Shimoyama M, Mizokami M, Hepatology research : the official journal of the Japan Society of Hepatology, 45, (12) 1220 - 1227,   2015年12月, 査読有り
  • Fatal reactivation of hepatitis B virus infection in a patient with adult T-cell leukemia-lymphoma receiving the anti-CC chemokine receptor 4 antibody mogamulizumab., Ifuku H, Kusumoto S, Tanaka Y, Totani H, Ishida T, Okada M, Murakami S, Mizokami M, Ueda R, Iida S, Hepatology research : the official journal of the Japan Society of Hepatology, 45, (13) 1363 - 1367,   2015年12月, 査読有り
  • Screening Performance for Frailty Among Older Patients With Cancer: A Cross-Sectional Observational Study of Two Approaches., Okuyama T, Sugano K, Iida S, Ishida T, Kusumoto S, Akechi T, Journal of the National Comprehensive Cancer Network : JNCCN, 13, (12) 1525 - 1531,   2015年12月, 査読有り
  • [Prognostic significance of tryptophan catabolism in adult T-cell leukemia/lymphoma]., Masaki A, Ishida T, Maeda Y, Suzuki S, Ito A, Takino H, Totani H, Yoshida T, Kinoshita S, Ogura H, Narita T, Ri M, Kusumoto S, Inagaki A, Komatsu H, Niimi A, Ueda R, Utsunomiya A, Inagaki H, Iida S, [Rinsho ketsueki] The Japanese journal of clinical hematology, 56, (11) 2295 - 2304,   2015年11月
  • Monitoring of Hepatitis B Virus (HBV) DNA and Risk of HBV Reactivation in B-Cell Lymphoma: A Prospective Observational Study., Kusumoto S, Tanaka Y, Suzuki R, Watanabe T, Nakata M, Takasaki H, Fukushima N, Fukushima T, Moriuchi Y, Itoh K, Nosaka K, Choi I, Sawa M, Okamoto R, Tsujimura H, Uchida T, Suzuki S, Okamoto M, Takahashi T, Sugiura I, Onishi Y, Kohri M, Yoshida S, Sakai R, Kojima M, Takahashi H, Tomita A, Maruyama D, Atsuta Y, Tanaka E, Suzuki T, Kinoshita T, Ogura M, Mizokami M, Ueda R, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 61, (5) 719 - 729,   2015年09月, 査読有り
  • Phase I study of pegylated liposomal doxorubicin in combination with bortezomib for Japanese patients with relapsed or refractory multiple myeloma., Kusumoto S, Sunami K, Inagaki M, Iida S, International journal of hematology, 101, (6) 578 - 584,   2015年06月, 査読有り
  • Prognostic Significance of Tryptophan Catabolism in Adult T-cell Leukemia/Lymphoma., Masaki A, Ishida T, Maeda Y, Suzuki S, Ito A, Takino H, Ogura H, Totani H, Yoshida T, Kinoshita S, Narita T, Ri M, Kusumoto S, Inagaki A, Komatsu H, Niimi A, Ueda R, Utsunomiya A, Inagaki H, Iida S, Clinical cancer research : an official journal of the American Association for Cancer Research, 21, (12) 2830 - 2839,   2015年06月, 査読有り
  • [Transplant-Related Mortality Following Allogeneic Hematopoietic Stem Cell Transplantation Using Fludarabine/Busulfan-Based Reduced-Intensity Conditioning - A Retrospective Analysis in a Single Institution]., Yoshida T, Kusumoto S, Masuda A, Totani H, Narita T, Masaki A, Ito A, Ri M, Ishida T, Komatsu H, Iida S, Gan to kagaku ryoho. Cancer & chemotherapy, 42, (6) 719 - 724,   2015年06月, 査読有り
  • Reactivation of hepatitis B virus (HBV) infection in adult T-cell leukemia-lymphoma patients with resolved HBV infection following systemic chemotherapy., Totani H, Kusumoto S, Ishida T, Masuda A, Yoshida T, Ito A, Ri M, Komatsu H, Murakami S, Mizokami M, Ueda R, Niimi A, Inagaki H, Tanaka Y, Iida S, International journal of hematology, 101, (4) 398 - 404,   2015年04月, 査読有り
  • CD30-positive primary bone marrow lymphoma mimicking Hodgkin lymphoma., Suzuki T, Kusumoto S, Masaki A, Ishida T, Inagaki H, Iida S, Mori F, International journal of hematology, 101, (2) 109 - 111,   2015年02月, 査読有り
  • [Reactivation of hepatitis B virus in patients treated with systemic chemotherapy]., Kusumoto S, Nihon rinsho. Japanese journal of clinical medicine, 73 Suppl 2, 375 - 379,   2015年02月
  • [Case Report; An intestinal extranodal NK/T cell lymphoma mimicking Crohn's disease]., Kominato S, Kusumoto S, Masuda A, Ishida T, Komatsu H, Mizoshita T, Joh T, Niimi A, Inagaki H, Iida S, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 104, (2) 298 - 301,   2015年02月, 査読有り
  • Medical Decision-Making Incapacity among Newly Diagnosed Older Patients with Hematological Malignancy Receiving First Line Chemotherapy: A Cross-Sectional Study of Patients and Physicians., Sugano K, Okuyama T, Iida S, Komatsu H, Ishida T, Kusumoto S, Uchida M, Nakaguchi T, Kubota Y, Ito Y, Takahashi K, Akechi T, PloS one, 10, (8) ,   2015年, 査読有り
  • Screening for and management of hepatitis B virus reactivation in patients treated with anti-B-cell therapy., Kusumoto S, Tobinai K, Hematology. American Society of Hematology. Education Program, 2014, (1) 576 - 583,   2014年12月, 査読有り
  • Strategy for preventing hepatitis B reactivation in patients with resolved hepatitis B virus infection after rituximab-containing chemotherapy., Kusumoto S, Tanaka Y, Mizokami M, Ueda R, Hepatology (Baltimore, Md.), 60, (2) 765 - 766,   2014年08月, 査読有り
  • [Recent progress of diagnosis and treatment for immune-mediated hematological diseases. Topics: IV. Recent topics: 1. Reactivation of hepatitis B virus and hepatitis C virus following immunosuppressive therapy]., Kusumoto S, Tanaka Y, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 103, (7) 1645 - 1653,   2014年07月
  • Reactivation of hepatitis B virus in a patient with adult T-cell leukemia-lymphoma receiving the anti-CC chemokine receptor 4 antibody mogamulizumab., Nakano N, Kusumoto S, Tanaka Y, Ishida T, Takeuchi S, Takatsuka Y, Akinaga S, Mizokami M, Ueda R, Utsunomiya A, Hepatology research : the official journal of the Japan Society of Hepatology, 44, (3) 354 - 357,   2014年03月, 査読有り
  • Antitumor effects of bevacizumab in a microenvironment-dependent human adult T-cell leukemia/lymphoma mouse model., Mori F, Ishida T, Ito A, Sato F, Masaki A, Narita T, Suzuki S, Yamada T, Takino H, Ri M, Kusumoto S, Komatsu H, Hishizawa M, Imada K, Takaori-Kondo A, Niimi A, Ueda R, Inagaki H, Iida S, European journal of haematology, 92, (3) 219 - 228,   2014年03月, 査読有り
  • HTLV-1 bZIP factor-specific CD4 T cell responses in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation., Narita T, Ishida T, Masaki A, Suzuki S, Ito A, Mori F, Yamada T, Ri M, Kusumoto S, Komatsu H, Miyazaki Y, Takatsuka Y, Utsunomiya A, Niimi A, Iida S, Ueda R, Journal of immunology (Baltimore, Md. : 1950), 192, (3) 940 - 947,   2014年02月, 査読有り
  • Amelanotic malignant melanoma of unknown primary origin metastasizing to the bone marrow: a case report and review of the literature., Suzuki T, Kusumoto S, Iida S, Tada T, Mori F, Internal medicine (Tokyo, Japan), 53, (4) 325 - 328,   2014年, 査読有り
  • Global real-time quantitative reverse transcription-polymerase chain reaction detecting proto-oncogenes associated with 14q32 chromosomal translocation as a valuable marker for predicting survival in multiple myeloma., Inagaki A, Tajima E, Uranishi M, Totani H, Asao Y, Ogura H, Masaki A, Yoshida T, Mori F, Ito A, Yano H, Ri M, Kayukawa S, Kataoka T, Kusumoto S, Ishida T, Hayami Y, Hanamura I, Komatsu H, Inagaki H, Matsuda Y, Ueda R, Iida S, Leukemia research, 37, (12) 1648 - 1655,   2013年12月, 査読有り
  • Is antiviral prophylaxis necessary to prevent hepatitis B virus (HBV) reactivation in patients with HBV-resolved infection receiving rituximab-containing chemotherapy?, Kusumoto S, Tanaka Y, Mizokami M, Ueda R, Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31, (35) ,   2013年12月, 査読有り
  • Autologous Tax-specific CTL therapy in a primary adult T cell leukemia/lymphoma cell-bearing NOD/Shi-scid, IL-2Rγnull mouse model., Masaki A, Ishida T, Suzuki S, Ito A, Mori F, Sato F, Narita T, Yamada T, Ri M, Kusumoto S, Komatsu H, Tanaka Y, Niimi A, Inagaki H, Iida S, Ueda R, Journal of immunology (Baltimore, Md. : 1950), 191, (1) 135 - 144,   2013年07月, 査読有り
  • Stevens-Johnson Syndrome associated with mogamulizumab treatment of adult T-cell leukemia / lymphoma., Ishida T, Ito A, Sato F, Kusumoto S, Iida S, Inagaki H, Morita A, Akinaga S, Ueda R, Cancer science, 104, (5) 647 - 650,   2013年05月, 査読有り
  • Successful salvage therapy using lenalidomide in a patient with relapsed multiple myeloma after allogeneic hematopoietic stem cell transplantation., Suzuki T, Kusumoto S, Yoshida T, Mori F, Ito A, Ri M, Ishida T, Komatsu H, Niimi A, Iida S, International journal of hematology, 97, (4) 540 - 543,   2013年04月, 査読有り
  • [Sustained remission with allogeneic peripheral blood stem cell transplantation and subsequent maintenance therapy with dasatinib in a patient with myeloblastic crisis of imatinib-resistant CML]., Narita T, Kayukawa S, Yoshida T, Kusumoto S, Kataoka T, [Rinsho ketsueki] The Japanese journal of clinical hematology, 54, (3) 279 - 283,   2013年03月, 査読有り
  • Angioimmunoblastic T-cell lymphoma mice model., Sato F, Ishida T, Ito A, Mori F, Masaki A, Takino H, Narita T, Ri M, Kusumoto S, Suzuki S, Komatsu H, Niimi A, Ueda R, Inagaki H, Iida S, Leukemia research, 37, (1) 21 - 27,   2013年01月, 査読有り
  • Tax is a potential molecular target for immunotherapy of adult T-cell leukemia/lymphoma., Suzuki S, Masaki A, Ishida T, Ito A, Mori F, Sato F, Narita T, Ri M, Kusumoto S, Komatsu H, Fukumori Y, Nishikawa H, Tanaka Y, Niimi A, Inagaki H, Iida S, Ueda R, Cancer science, 103, (10) 1764 - 1773,   2012年10月, 査読有り
  • Adalimumab therapy following granulocyte and monocyte adsorptive apheresis in a patient with Crohn's disease accompanied by chronic myeloid leukemia., Mizoshita T, Tanida S, Kusumoto S, Ozeki K, Tsukamoto H, Ebi M, Mori Y, Kataoka H, Kamiya T, Joh T, Clinical journal of gastroenterology, 5, (4) 302 - 306,   2012年08月, 査読有り
  • Virological and clinical characteristics on reactivation of occult hepatitis B in patients with hematological malignancy., Sugauchi F, Tanaka Y, Kusumoto S, Matsuura K, Sugiyama M, Kurbanov F, Ueda R, Mizokami M, Journal of medical virology, 83, (3) 412 - 418,   2011年03月, 査読有り
  • Cladribine combined with rituximab (R-2-CdA) therapy is an effective salvage therapy in relapsed or refractory indolent B-cell non-Hodgkin lymphoma., Nagai H, Ogura M, Kusumoto S, Takahashi N, Yamaguchi M, Takayama N, Kinoshita T, Motoji T, Ohyashiki K, Kosugi H, Matsuda S, Ohnishi K, Omachi K, Hotta T, European journal of haematology, 86, (2) 117 - 123,   2011年02月, 査読有り
  • Clinical significance of hepatitis B virus (HBV)-DNA monitoring to detect HBV reactivation after systemic chemotherapy., Kusumoto S, Tanaka Y, Mizokami M, Ueda R, Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 29, (4) ,   2011年02月, 査読有り
  • Reactivation of hepatitis B virus following rituximab-plus-steroid combination chemotherapy., Kusumoto S, Tanaka Y, Ueda R, Mizokami M, Journal of gastroenterology, 46, (1) 9 - 16,   2011年01月, 査読有り
  • [A case of T-cell lymphoblastic lymphoma with multiple patchy shadows in both lung fields]., Nakao M, Oguri T, Yoshida T, Harada K, Tomita Y, Inagaki A, Kusumoto S, Iida S, Sato S, Ueda R, Gan to kagaku ryoho. Cancer & chemotherapy, 38, (1) 129 - 131,   2011年01月, 査読有り
  • Hepatic toxicity and prognosis in hepatitis C virus-infected patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy regimens: a Japanese multicenter analysis., Ennishi D, Maeda Y, Niitsu N, Kojima M, Izutsu K, Takizawa J, Kusumoto S, Okamoto M, Yokoyama M, Takamatsu Y, Sunami K, Miyata A, Murayama K, Sakai A, Matsumoto M, Shinagawa K, Takaki A, Matsuo K, Kinoshita T, Tanimoto M, Blood, 116, (24) 5119 - 5125,   2010年12月, 査読有り
  • [Preemptive therapy for HBV reactivation by serial HBV-DNA monitoring]., Kusumoto S, Tanaka Y, Mizokami M, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 107, (9) 1441 - 1449,   2010年09月
  • Reactivation of hepatitis B virus in HBsAg-negative patients with multiple myeloma: two case reports., Yoshida T, Kusumoto S, Inagaki A, Mori F, Ito A, Ri M, Ishida T, Komatsu H, Iida S, Sugauchi F, Tanaka Y, Mizokami M, Ueda R, International journal of hematology, 91, (5) 844 - 849,   2010年06月, 査読有り
  • [Anti-CCR4 monoclonal antibody as a novel therapy for advanced mycosis fungoides and Sézary syndrome]., Yano H, Ishida T, Inagaki A, Ishii T, Ri M, Ito A, Kusumoto S, Komatsu H, Iida S, Inagaki H, Ueda R, [Rinsho ketsueki] The Japanese journal of clinical hematology, 50, (12) 1671 - 1678,   2009年12月, 査読有り
  • The Asn505 mutation of the c-MPL gene, which causes familial essential thrombocythemia, induces autonomous homodimerization of the c-Mpl protein due to strong amino acid polarity., Ding J, Komatsu H, Iida S, Yano H, Kusumoto S, Inagaki A, Mori F, Ri M, Ito A, Wakita A, Ishida T, Nitta M, Ueda R, Blood, 114, (15) 3325 - 3328,   2009年10月, 査読有り
  • Defucosylated anti-CCR4 monoclonal antibody exerts potent ADCC against primary ATLL cells mediated by autologous human immune cells in NOD/Shi-scid, IL-2R gamma(null) mice in vivo., Ito A, Ishida T, Utsunomiya A, Sato F, Mori F, Yano H, Inagaki A, Suzuki S, Takino H, Ri M, Kusumoto S, Komatsu H, Iida S, Inagaki H, Ueda R, Journal of immunology (Baltimore, Md. : 1950), 183, (7) 4782 - 4791,   2009年10月, 査読有り
  • Small-cell lung cancer arising after chemotherapy for a patient with lymphoma of pulmonary mucosa-associated lymphoid tissue-a case report., Nakao M, Oguri T, Maeno K, Kusumoto S, Ota C, Takakuwa O, Uemura T, Ozasa H, Iwashima Y, Miyazaki M, Kutsuna T, Nakamura A, Inagaki H, Sato S, Ueda R, Gan to kagaku ryoho. Cancer & chemotherapy, 36, (10) 1711 - 1714,   2009年10月, 査読有り
  • Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rgamma(null) mouse model., Ito A, Ishida T, Yano H, Inagaki A, Suzuki S, Sato F, Takino H, Mori F, Ri M, Kusumoto S, Komatsu H, Iida S, Inagaki H, Ueda R, Cancer immunology, immunotherapy : CII, 58, (8) 1195 - 1206,   2009年08月, 査読有り
  • [The role of physicians in charge of cancer chemotherapy in oncological management]., Kusumoto S, Komatsu H, Ueda R, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 98, (8) 1947 - 1951,   2009年08月
  • Expression of the ULBP ligands for NKG2D by B-NHL cells plays an important role in determining their susceptibility to rituximab-induced ADCC., Inagaki A, Ishida T, Yano H, Ishii T, Kusumoto S, Ito A, Ri M, Mori F, Ding J, Komatsu H, Iida S, Ueda R, International journal of cancer, 125, (1) 212 - 221,   2009年07月, 査読有り
  • Reactivation of hepatitis B virus following systemic chemotherapy for malignant lymphoma., Kusumoto S, Tanaka Y, Mizokami M, Ueda R, International journal of hematology, 90, (1) 13 - 23,   2009年07月, 査読有り
  • Bortezomib-induced apoptosis in mature T-cell lymphoma cells partially depends on upregulation of Noxa and functional repression of Mcl-1., Ri M, Iida S, Ishida T, Ito A, Yano H, Inagaki A, Ding J, Kusumoto S, Komatsu H, Utsunomiya A, Ueda R, Cancer science, 100, (2) 341 - 348,   2009年02月, 査読有り
  • Overexpression of carboxylesterase-2 results in enhanced efficacy of topoisomerase I inhibitor, irinotecan (CPT-11), for multiple myeloma., Yano H, Kayukawa S, Iida S, Nakagawa C, Oguri T, Sanda T, Ding J, Mori F, Ito A, Ri M, Inagaki A, Kusumoto S, Ishida T, Komatsu H, Inagaki H, Suzuki A, Ueda R, Cancer science, 99, (11) 2309 - 2314,   2008年11月, 査読有り
  • Defucosylated anti CC chemokine receptor 4 monoclonal antibody combined with immunomodulatory cytokines: a novel immunotherapy for aggressive/refractory Mycosis fungoides and Sezary syndrome., Yano H, Ishida T, Inagaki A, Ishii T, Ding J, Kusumoto S, Komatsu H, Iida S, Inagaki H, Ueda R, Clinical cancer research : an official journal of the American Association for Cancer Research, 13, (21) 6494 - 6500,   2007年11月, 査読有り
  • [A case of neurolymphomatosis diagnosed with FDG-PET]., Hoshikawa Y, Oguri T, Hattori M, Uematsu N, Matsukawa N, Yamawaki T, Kusumoto S, Ojika K, Rinsho shinkeigaku = Clinical neurology, 47, (7) 437 - 440,   2007年07月, 査読有り
  • T-cell large granular lymphocyte leukemia of donor origin after cord blood transplantation., Kusumoto S, Mori S, Nosaka K, Morita-Hoshi Y, Onishi Y, Kim SW, Watanabe T, Heike Y, Tanosaki R, Takaue Y, Tobinai K, Clinical lymphoma & myeloma, 7, (7) 475 - 479,   2007年07月, 査読有り
  • Regulatory T-cell function of adult T-cell leukemia/lymphoma cells., Yano H, Ishida T, Inagaki A, Ishii T, Kusumoto S, Komatsu H, Iida S, Utsunomiya A, Ueda R, International journal of cancer, 120, (9) 2052 - 2057,   2007年05月, 査読有り
  • Unrelated-donor bone marrow transplantation with a conditioning regimen including fludarabine, busulfan, and 4 Gy total body irradiation., Onishi Y, Mori S, Kusumoto S, Sugimoto K, Akahane D, Morita-Hoshi Y, Kim SW, Fukuda T, Heike Y, Tanosaki R, Tobinai K, Takaue Y, International journal of hematology, 85, (3) 256 - 263,   2007年04月, 査読有り
  • Phase I study of radioimmunotherapy with an anti-CD20 murine radioimmunoconjugate ((90)Y-ibritumomab tiuxetan) in relapsed or refractory indolent B-cell lymphoma., Watanabe T, Terui S, Itoh K, Terauchi T, Igarashi T, Usubuchi N, Nakata M, Nawano S, Sekiguchi N, Kusumoto S, Tanimoto K, Kobayashi Y, Endo K, Seriu T, Hayashi M, Tobinai K, Cancer science, 96, (12) 903 - 910,   2005年12月, 査読有り
  • Diffuse large B-cell lymphoma with extra Bcl-2 gene signals detected by FISH analysis is associated with a "non-germinal center phenotype"., Kusumoto S, Kobayashi Y, Sekiguchi N, Tanimoto K, Onishi Y, Yokota Y, Watanabe T, Maeshima AM, Ishida T, Inagaki H, Matsuno Y, Ueda R, Tobinai K, The American journal of surgical pathology, 29, (8) 1067 - 1073,   2005年08月, 査読有り
  • CC chemokine receptor 4-positive diffuse large B-cell lymphoma involving the skin: a case report., Ishida T, Inagaki H, Kusumoto S, Inagaki A, Komatsu H, Iida S, Harada S, Takeuchi G, Uedaa R, International journal of hematology, 82, (2) 148 - 151,   2005年08月, 査読有り
  • Follicular lymphoma subgrouping by fluorescence in situ hybridization analysis., Sekiguchi N, Kobayashi Y, Yokota Y, Kusumoto S, Tanimoto K, Watanabe T, Matsuno Y, Tobinai K, Cancer science, 96, (2) 77 - 82,   2005年02月, 査読有り
  • Two entities of precursor T-cell lymphoblastic leukemia/lymphoma based on radiologic and immunophenotypic findings., Onishi Y, Matsuno Y, Tateishi U, Maeshima AM, Kusumoto M, Terauchi T, Kusumoto S, Sekiguchi N, Tanimoto K, Watanabe T, Kobayashi Y, Tobinai K, International journal of hematology, 80, (1) 43 - 51,   2004年07月, 査読有り
  • T(11;18)-bearing pulmonary mucosa-associated lymphoid tissue lymphoma responding to cladribine., Kusumoto S, Kobayashi Y, Tanimoto TE, Hasegawa T, Yokota Y, Tanimoto K, Sekiguchi N, Narabayashi M, Watanabe T, Matsuno Y, Tobinai K, International journal of hematology, 80, (1) 70 - 74,   2004年07月, 査読有り
  • Primary mediastinal large B-cell lymphoma: a single-institution clinical study in Japan., Sekiguchi N, Nishimoto J, Tanimoto K, Kusumoto S, Onishi Y, Watanabe T, Kobayashi Y, Asamura H, Kagami Y, Matsuno Y, Tobinai K, International journal of hematology, 79, (5) 465 - 471,   2004年06月, 査読有り
  • Clinical significance of CCR4 expression in adult T-cell leukemia/lymphoma: its close association with skin involvement and unfavorable outcome., Ishida T, Utsunomiya A, Iida S, Inagaki H, Takatsuka Y, Kusumoto S, Takeuchi G, Shimizu S, Ito M, Komatsu H, Wakita A, Eimoto T, Matsushima K, Ueda R, Clinical cancer research : an official journal of the American Association for Cancer Research, 9, (10 Pt 1) 3625 - 3634,   2003年09月, 査読有り
  • [Progress in therapy for leukemia and the diagnosis (discussion)]., Nitta M, Miyawaki S, Sakamaki H, Onishi K, Kusumoto S, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 92, (6) 1048 - 1064,   2003年06月
  • Frequent occurrence of CCND1 deregulation in patients with early stages of plasma cell dyscrasia., Miura K, Iida S, Hanamura I, Kato M, Banno S, Ishida T, Kusumoto S, Takeuchi G, Miwa H, Nitta M, Inagaki H, Eimoto T, Nomura K, Taniwaki M, Ueda R, Cancer science, 94, (4) 350 - 354,   2003年04月, 査読有り


Copyright © MEDIA FUSION Co.,Ltd. All rights reserved.